Registered number
13878471
HERMES CLINICAL RESEARCH LIMITED
Filleted Accounts
31 January 2024
HERMES CLINICAL RESEARCH LIMITED
Registered number: 13878471
Balance Sheet
as at 31 January 2024
Notes 2024 2023
£ £
Current assets
Cash at bank and in hand 7,404 15,852
Creditors: amounts falling due within one year 3 (10,399) (14,383)
Net current (liabilities)/assets (2,995) 1,469
Net (liabilities)/assets (2,995) 1,469
Capital and reserves
Called up share capital 1 1
Profit and loss account (2,996) 1,468
Shareholder's funds (2,995) 1,469
Number Number
Average number of employees 1 1
The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The member has not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Hend Essam Eldin Ahmed Abdelhakim
Director
Approved by the board on 8 October 2024
HERMES CLINICAL RESEARCH LIMITED 13878471 false 2023-02-01 2024-01-31 2024-01-31 VT Final Accounts April 2024 Hend Essam Eldin Ahmed Abdelhakim No description of principal activity 13878471 core:WithinOneYear 2023-01-31 13878471 core:ShareCapital 2023-01-31 13878471 core:RetainedEarningsAccumulatedLosses 2023-01-31 13878471 2023-02-01 2024-01-31 13878471 bus:PrivateLimitedCompanyLtd 2023-02-01 2024-01-31 13878471 bus:AuditExemptWithAccountantsReport 2023-02-01 2024-01-31 13878471 bus:Director40 2023-02-01 2024-01-31 13878471 bus:FRS102 2023-02-01 2024-01-31 13878471 bus:FilletedAccounts 2023-02-01 2024-01-31 13878471 2024-01-31 13878471 core:WithinOneYear 2024-01-31 13878471 core:ShareCapital 2024-01-31 13878471 core:RetainedEarningsAccumulatedLosses 2024-01-31 13878471 2023-01-31 iso4217:GBP xbrli:pure